Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 50: 801-802, 2004; 10.1373/clinchem.2004.032672
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nolte, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nolte, F. S.
Related Collections
Right arrow Laboratory Management
Right arrow Molecular Diagnostics and Genetics
Right arrow Hemostasis and Thrombosis
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2004;50:801-802.)
© 2004 American Association for Clinical Chemistry, Inc.

Editorials

Novel Internal Controls For Real-Time PCR Assays

Frederick S. Nolte1

1 Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, E-mail fnolte@emory.edu

The first 20% of the full text of this article appears below.

In the 19 years since the first descriptions of the PCR (1), nucleic acid amplification methods have made the transition from research to clinical laboratories. Molecular diagnostics are now firmly established as part of laboratory medicine, with applications in genetics, oncology, pharmacology, and infectious disease. Routine diagnostic applications of these methods have been made possible by the thoughtful use of controls coupled with laboratory practices intended to reduce false-positive and -negative results (2)(3)(4).

Nucleic acid amplification assays are prone to inhibition by a variety of substances found in clinical samples. Although the identities and biochemical mechanisms of action of many inhibitors remain unclear, bile salts and complex polysaccharides in feces (5), heme in blood (6), and urea in urine(7) have all been shown to inhibit PCR, probably through interference with the binding and/or polymerization activity of DNA polymerases. Carryover of reagents used for isolation of nucleic acids from clinical specimens can also inhibit amplification reactions. Other causes of false-negative results include target nucleic acid degradation, sample processing errors, thermal cycler malfunction, and in reverse transcription-PCR, failure of the reverse transcription step.

A simple approach to detect inhibitors is to add the target nucleic acid to a separate aliquot of the sample after processing. Addition of the external control to a separate reaction, however, doubles the cost of the assay, and the approach may be unworkable if batch sizes are large. Moreover, addition of the control after sample processing . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
Q. Huang, Y. Cheng, Q. Guo, and Q. Li
Preparation of a chimeric armored RNA as a versatile calibrator for multiple virus assays.
Clin. Chem., July 1, 2006; 52(7): 1446 - 1448.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Drosten, M. Panning, J. F. Drexler, F. Hansel, C. Pedroso, J. Yeats, L. K. de Souza Luna, M. Samuel, B. Liedigk, U. Lippert, et al.
Ultrasensitive Monitoring of HIV-1 Viral Load by a Low-Cost Real-Time Reverse Transcription-PCR Assay with Internal Control for the 5' Long Terminal Repeat Domain
Clin. Chem., July 1, 2006; 52(7): 1258 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
S. Burggraf, U. Reischl, N. Malik, M. Bollwein, L. Naumann, and B. Olgemoller
Comparison of an Internally Controlled, Large-Volume LightCycler Assay for Detection of Mycobacterium tuberculosis in Clinical Samples with the COBAS AMPLICOR Assay
J. Clin. Microbiol., April 1, 2005; 43(4): 1564 - 1569.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
L. L. M. Poon, C. S. W. Leung, K. H. Chan, J. H. C. Lee, K. Y. Yuen, Y. Guan, and J. S. M. Peiris
Detection of Human Influenza A Viruses by Loop-Mediated Isothermal Amplification
J. Clin. Microbiol., January 1, 2005; 43(1): 427 - 430.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.